Drug intelligence / Profile preview

influenza vaccine 2006-2007 formulation

Development stage
Approved
Lead developer
Sanofi Pasteur
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Intranasal
01

Overview

The influenza vaccine 2006-2007 formulation refers to the trivalent seasonal vaccines produced for the 2006-2007 Northern Hemisphere influenza season. Following WHO recommendations from February 2006, the formulation targeted three specific viral strains: an A/New Caledonia/20/99 (H1N1)-like virus, an A/Wisconsin/67/2005 (H3N2)-like virus, and a B/Malaysia/2506/2004-like virus (B/Victoria lineage). These vaccines were available in various forms, including inactivated split-virion or subunit injections (e.g., Fluzone, Fluarix, Fluvirin) and a live attenuated intranasal spray (FluMist). They were indicated for the prevention of seasonal influenza infection in children and adults.

Brand names
FluzoneFluarixFluLavalFluvirinFluMist
Other names
2006-2007 seasonal influenza vaccine2006-2007 Northern Hemisphere influenza vaccine
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on influenza vaccine 2006-2007 formulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on influenza vaccine 2006-2007 formulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call